Search

Kaempferol, a natural flavonoid abundantly found in plants, is known to have pharmacological properties, such as anti-inflammatory and anti-cancer effects. In this study, we investigated the antiviral effects of kaempferol against a varicella-zoster virus (VZV) clinical isolate in vitro. We found that kaempferol significantly inhibited VZV replication without exhibiting cytotoxicity. Kaempferol exerted its antiviral effect at a similar stage of the VZV life cycle as acyclovir, which inhibits VZV DNA replication. Taken together, our results suggest that kaempferol inhibits VZV infection by blocking the DNA replication stage in the viral life cycle. [ABSTRACT FROM AUTHOR]

We previously reported that human cytomegalovirus (HCMV) 86 kDa immediate-early 2 gene product (IE86) promotes proteasome-dependent degradation of STING. In the present study, we determined the specific residues of IE86 responsible for STING degradation using a STING-firefly luciferase fusion protein expression system for quantitative meas-urement of STING protein levels. IE86 amino acids (aa) 136-289 were sufficient to promote STING degradation and further induced down-regulation of 2′3′-cyclic GMP-AMP (cGAMP)-mediated IFN-β promoter activation. Interestingly, transactivation domains (TAD) of the IE86 protein located at the N- and C-termini were required for down-regulation of Toll/interleukin-1 receptor (TIR) domain-containing adaptor-inducing interferon β (IFN-β) (TRIF)-mediated IFN-β-and p65/RelA-induced NF-κB-dependent promoter activation while amino acids (aa) 136-289 had no significant effects. Our collective data suggest that the IE86 protein utilizes the aa 136-289 region to promote STING degradation and inhibit the cGAS-STING pathway. [ABSTRACT FROM AUTHOR]

Graphene aerogel‐supported manganese ferrite (MnxFe3−xO4/GAs) and reduced‐graphene oxide/manganese ferrite composite (MnFe2O4/rGO) were synthesized and studied as cathode catalysts for oxygen reduction reactions in urea/O2 fuel cells. MnFe2O4/GAs exhibited a 3D framework with a continuous macroporous structure. Among the investigated Fe/Mn ratios, the more positive oxygen reduction onset potential was observed with Fe/Mn=2/1. The half‐wave potential of MnFe2O4/GAs was considerably more positive than that of MnFe2O4/rGO and comparable with that of Pt/C, while the stability of MnFe2O4/GAs significantly higher than that of Pt/C. The best urea/O2 fuel cell performance was also observed with the MnFe2O4/GAs. The MnFe2O4/GAs exhibited an OCV of 0.713 V and a maximum power density of 1.7 mW cm−2 at 60 °C. Thus, this work shows that 3D structured graphene aerogel‐supported MnFe2O4 catalysts can be used as an efficient cathode material for alkaline fuel cells. [ABSTRACT FROM AUTHOR]

Anion conducting composite membranes were synthesized by cross-linking hydroxide conducting 1,4-diazabicyclo-[2.2.2]-octane (DABCO)–cellulose nanofibers (isolated from Citrus tangerine) with DABCO–polysulfone using 1,4-dibromo butane. The content of quaternized cellulose was adjusted to control the ion exchange capacity (IEC) and the ionic conductivity. The structural and morphological characteristics of the membranes were determined by Fourier transform infrared (FTIR) spectroscopy, proton nuclear magnetic resonance spectroscopy (1H-NMR), X-ray diffraction (XRD) and scanning electron microscopy (SEM). The microphase structure of the membranes was studied by atomic force microscopy (AFM). The effects of the DABCO–cellulose on water uptake (WU), ion exchange capacity (IEC) and ionic conductivity were investigated. The cross-linking of the quaternized cellulose with the polymer main chains formed a bedform type structure, ensuing good chemical and excellent mechanical stability of the membranes in aqueous and alkaline media. The composite membranes showed conductivity in the range of ca. 39–74 mS cm−1 at 25 °C and reached 128 mS cm−1 at 80 °C, derived from the nanophase separation and densely distributed ionic channels. Such a strategy provides a valuable prospect to design high anion conducting membranes for fuel cell applications. [ABSTRACT FROM AUTHOR]

ABSTRACT Biocompatibility, sensing, and self-actuation are very important features for a therapeutic biomedical microrobot. As a new concept for tumor theragnosis, this paper proposes a monocyte-based microrobots, which are combining the phagocytosis and engulfment activities containing human acute monocytic leukemia cell line (THP-1) with various sized polystyrene microbeads are engulfed instead of a therapeutic drug. For the validation of the blood vessel barrier-penetrating activity of the monocyte-based microrobot, we fabricate a new cell migration assay with monolayer-cultured endothelial cell (HUVEC), similar with the blood vessels. We perform the penetrating chemotactic motility of the monocyte-based microrobot using various types of the chemo-attractants, such as monocyte chemotactic protein (MCP)-1, human breast cancer cell lines (MCF7)-cell lysates, and -contained alginate spheroids. The monocyte-based microrobot show chemotactic transmigrating motilities similar with what an actual monocyte does. This new paradigm of a monocyte-based microrobot having various useful properties such as biocompatibility, sensing, and self-actuation can become the basis of a biomedical microrobot using monocytes for diagnosis and therapy of various diseases. Biotechnol. Bioeng. 2014;111: 2132-2138. © 2014 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]

Crack prevention of biodegradable polymer coatings on drug-eluting stents was investigated by introducing a nano-coupled layer at the interface between the metal surface and the polymer coating layer using surface-initiated ring-opening polymerization of ε-caprolactone. Poly(d,l-lactide-co-glycolide) coating on cobalt-chromium control and ricinoleic acid-poly(caprolactone)–grafted cobalt-chromium was carried out using electrospraying. The cracking of the biodegradable polymer coating on drug-eluting stents during ballooning was addressed by introducing a nano-coupled interlayer on the cobalt-chromium surface. The ricinoleic acid-poly(caprolactone) nano-coupled interlayer and poly(d,l-lactide-co-glycolide)-coated top layer were characterized using attenuated total reflection Fourier transform infrared, contact angle, ellipsometry, X-ray photoelectron spectroscopy, and atomic force microscopy. Based on scratch tests, the nano-coupled samples had stronger interfacial adhesion compared to the control sample without the nano-coupled layer. Scanning electron microscope images indicated that the cracking on the poly(d,l-lactide-co-glycolide) coating was addressed. Introducing a nano-coupling interlayer may be an important strategy to preventing polymer coating cracking on drug-eluting stents. [ABSTRACT FROM AUTHOR]

ABSTRACT A bacteria-based microrobot (bacteriobot) was proposed and investigated as a new type of active drug delivery system because of its useful advantages, such as active tumor targeting, bacteria-mediated tumor diagnosis, and therapy. In this study, we fabricated a bacteriobot with enhanced motility by selective attachment of flagellar bacteria ( Salmonella typhimurium). Through selective bovine serum albumin (BSA) pattering on hydrophobic polystyrene (PS) microbeads, many S. typhimurium could be selectively attached only on the unpatterned surface of PS microbead. For the evaluation of the chemotactic motility of the bacteriobot, we developed a microfluidic chamber which can generate a stable concentration gradient of bacterial chemotactic chemicals. Prior to the evaluation of the bacteriobot, we first evaluated the directional chemotactic motility of S. typhimurium using the proposed microfluidic chamber, which contained a bacterial chemo-attractant ( L-aspartic acid) and a chemo-repellent (NiSO4), respectively. Compared to density of the control group in the microfluidic chamber without any chemical gradient, S. typhimurium increased by about 16% in the L-aspartic acid gradient region and decreased by about 22% in the NiSO4 gradient region. Second, we evaluated the bacteriobot's directional motility by using this microfluidic chamber. The chemotactic directional motility of the bacteriobot increased by 14% and decreased by 13% in the concentration gradients of L-aspartic acid and NiSO4, respectively. These results confirm that the bacteriobot with selectively patterned S. typhimurium shows chemotaxis motility very similar to that of S. typhimurium. Moreover, the directional motilities of the bacteria and bacteriobot could be demonstrated quantitatively through the proposed microfluidic chamber. Biotechnol. Bioeng. 2014;111: 134-143. © 2013 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]

Recently, the locomotion of a microrobot wirelessly actuated by electromagnetic actuation systems has been studied in many ways. Because of the inherent characteristics of an electromagnetic field, however, the magnetic field of each coil in the electromagnetic actuation system induces magnetic field interferences, which can distort the desired electromagnetic field, preventing the microrobot from following the desired path. In this article, we used two pairs of Helmholtz coils and two pairs of Maxwell coils in a two-dimensional electromagnetic actuation system. Generally, the two pairs of Helmholtz coils generate the torque for the rotation of the microrobot and the two pairs of Maxwell coils generate the propulsion force of the microrobot. Both pairs of Helmholtz and Maxwell coils have to work to simultaneously align and propel the microrobot in a desired direction. In this situation, however, the electromagnetic fields produced by the Helmholtz coils can interfere with those produced by the Maxwell coils. This interference is closely dependent on the position of the microrobot in the region of interest inside the electromagnetic coils system. This means that the alignment direction and propulsion force of the microrobot can be distorted according to the position of the microrobot. Therefore, we propose a compensation algorithm for the electromagnetic field interference using the position information of the microrobot to correct the magnetic field interferences. First, the interference of an electromagnetic field obeying the Biot–Savart law is analyzed by numerical analysis. Second, a position-based compensation algorithm for the locomotion of a microrobot is proposed. Various locomotion tests of a microrobot verified that the proposed compensation algorithm could reduce the normalized average tracking error from 5.25% to 1.92%. [ABSTRACT FROM AUTHOR]

The aim of this study was to explore the protective effects of bioactive compounds from the fruit of the mulberry tree (Morus alba L.) against cisplatin-induced apoptosis in LLC-PK1 pig kidney epithelial cells. Morus alba fruit is a well-known edible fruit commonly used in traditional folk medicine. Chemical investigation of M. alba fruit resulted in the isolation and identification of six phytosterols (1–6). Their structures were determined as 7-ketositosterol (1), stigmast-4-en-3β-ol-6-one (2), (3β,6α)-stigmast-4-ene-3,6-diol (3), stigmast-4-ene-3β,6β-diol (4), 7β-hydroxysitosterol 3-O-β-d-glucoside (5), and 7α-hydroxysitosterol 3-O-β-d-glucoside (6) by analyzing their physical and spectroscopic data as well as liquid chromatography/mass spectrometry data. All compounds displayed protective effects against cisplatin-induced LLC-PK1 cell damage, improving cisplatin-induced cytotoxicity to more than 80% of the control value. Compound 1 displayed the best effect at a relatively low concentration by inhibiting the percentage of apoptotic cells following cisplatin treatment. Its molecular mechanisms were identified using Western blot assays. Treatment of LLC-PK1 cells with compound 1 decreased the upregulated phosphorylation of p38 and c-Jun N-terminal kinase (JNK) following cisplatin treatment. In addition, compound 1 significantly suppressed cleaved caspase-3 in cisplatin-induced LLC-PK1 cells. Taken together, these findings indicated that cisplatin-induced apoptosis was significantly inhibited by compound 1 in LLC-PK1 cells, thereby supporting the potential of 7-ketositosterol (1) as an adjuvant candidate for treating cisplatin-induced nephrotoxicity. [ABSTRACT FROM AUTHOR]

The aim of our study was to investigate the effect of three lignans (schisandrol A, schisandrol B, and schisandrin C) on insulin secretion in rat INS-1 pancreatic β-cells and glucose uptake in mouse C2C12 skeletal muscle cells. Schisandrol A and schisandrin C enhanced insulin secretion in response to high glucose levels with no toxic effects on INS-1 cells. The effect of schisandrin C was superior to that of gliclazide (positive control), a drug commonly used to treat type 2 diabetes (T2D). In addition, western blot analysis showed that the expression of associated proteins, including peroxisome proliferator-activated receptor γ (PPARγ), pancreatic and duodenal homeobox 1 (PDX-1), phosphatidylinositol 3-kinase (PI3K), Akt, and insulin receptor substrate-2 (IRS-2), was increased in INS-1 cells after treatment with schisandrin C. In addition, insulin secretion effect of schisandrin C were enhanced by the Bay K 8644 (L-type Ca2+ channel agonist) and glibenclamide (K+ channel blocker), were abolished by the nifedipine (L-type Ca2+ channel blocker) and diazoxide (K+ channel activator). Moreover, schisandrin C enhanced glucose uptake with no toxic effects on C2C12 cells. Western blot analysis showed that the expression of associated proteins, including insulin receptor substrate-1 (IRS-1), AMP-activated protein kinase (AMPK), PI3K, Akt, glucose transporter type 4 (GLUT-4), was increased in C2C12 cells after treatment with schisandrin C. Schisandrin C may improve hyperglycemia by enhancing insulin secretion in pancreatic β-cells and improving glucose uptake into skeletal muscle cells. Our findings may provide evidence that schisandrin C may be beneficial in devising novel anti-T2D strategies. [ABSTRACT FROM AUTHOR]

Abstract: Nanopowders of FeAl and Al2O3 were synthesized from Fe2O3 and Al by high energy ball milling. The sizes of FeAl and Al2O3 were 4 and 57nm, respectively. A dense nanostuctured FeAl–Al2O3 composite was consolidated by a high-frequency induction heated sintering method within two minutes from mechanically synthesized powders of FeAl and Al2O3. The grain size, sintering behavior and hardness of the sintered FeAl–Al2O3 composite were investigated. [Copyright &y& Elsevier]

Graphene aerogel-supported manganese ferrite (Mn x Fe 3-x O 4 /GAs) and reduced-graphene oxide/manganese ferrite composite (MnFe 2 O 4 /rGO) were synthesized and studied as cathode catalysts for oxygen reduction reactions in urea/O 2 fuel cells. MnFe 2 O 4 /GAs exhibited a 3D framework with a continuous macroporous structure. Among the investigated Fe/Mn ratios, the more positive oxygen reduction onset potential was observed with Fe/Mn=2/1. The half-wave potential of MnFe 2 O 4 /GAs was considerably more positive than that of MnFe 2 O 4 /rGO and comparable with that of Pt/C, while the stability of MnFe 2 O 4 /GAs significantly higher than that of Pt/C. The best urea/O 2 fuel cell performance was also observed with the MnFe 2 O 4 /GAs. The MnFe 2 O 4 /GAs exhibited an OCV of 0.713 V and a maximum power density of 1.7 mW cm -2 at 60 °C. Thus, this work shows that 3D structured graphene aerogel-supported MnFe 2 O 4 catalysts can be used as an efficient cathode material for alkaline fuel cells., Competing Interests: The authors declare no conflict of interest.

Sirolimus (SRL) release from the biodegradable poly(l-lactic-co-glycolic acid) (PLGA) matrix was investigated for the application of drug-eluting stents (DES). In particular, this study focused on whether various organic solvents affect the interaction between SRL and PLGA and the formation of microstructures during ultrasonic coating. The SRL-loaded PLGA coated by tetrahydrofuran or acetone showed a significant initial burst, whereas that from acetonitrile was constantly released during a period of 21 days. On the basis of these results, the interactions at the molecular level of SRL with the polymer matrix were estimated according to various organic solvents. Although the topographies of the coated surface were obviously different, the correlation between surface roughness and SRL release was very poor. Irrespective of organic solvents, FT-IR data showed significantly weak SRL-PLGA interactions. From the result of wide-angle X-ray diffraction, it was confirmed that SRL was dispersed in an amorphous state in the polymer matrix after ultrasonic coating. The glass-transition temperature was also influenced by organic solvents, resulting in a plasticizing effect. The particle size of SRL appeared to determine the release profile from the PLGA matrix, which was the combination of diffusion and polymer degradation at an SRL size of more than 800 nm and the Fickian release at that of less than 300 nm. Therefore, organic solvents can lead to a heterogeneous microstructure in the SRL-loaded PLGA matrix, which is at or near the surface, consisting of aggregated drug- and polymer-rich regions. It is expected that the drug release can be controlled by physicochemical properties of organic solvents, and this study can be used effectively for localized drug release in biomedical devices such as drug-eluting stents.

During the balloon expansion of several commercially available drug-eluting stents, various types of defects in the polymer layer have been observed. The aim of this study is to prevent these defects by increasing the interfacial adhesion between the metal substrate and the drug-in-polymer matrix using poly(caprolactone) (PCL) brushes onto a cobalt-chromium (Co-Cr or CC) alloy surface. The chemical modification of the Co-Cr surface was accomplished by grafting ricinoleic acid (RA) onto the metal substrate followed by surface-initiated ring opening polymerization of ε-caprolactone. The unmodified, RA-grafted (CC-RA), and PCL-grafted Co-Cr substrates (CC-RA-PCL3D and CC-RA-PCL6D) were characterized by various surface analyses. Poly(d,l-lactide) containing sirolimus was spray coated onto the unmodified and modified substrates. The adhesion property of the polymer coating on the PCL-grafted surfaces was improved compared to those of other samples. Among all of the drug-in-polymer coated samples, both CC-RA-PCL3D and CC-RA-PCL6D exhibited a stabilized drug release profile over 49 days. It was also revealed that CC-RA-PCL6D showed the slowest drug release of all the samples. On the basis of these results, the proposed nanocoupling method has shown not only improved adhesion of the drug-in-polymer matrix to the Co-Cr substrate but also controlled drug release.

A systematic review, covering fabrication of nanoscale patterns by laser interference lithography (LIL) and their applications for optical devices is provided. LIL is a patterning method. It is a simple, quick process over a large area without using a mask. LIL is a powerful technique for the definition of large-area, nanometer-scale, periodically patterned structures. Patterns are recorded in a light-sensitive medium that responds nonlinearly to the intensity distribution associated with the interference of two or more coherent beams of light. The photoresist patterns produced with LIL are the platform for further fabrication of nanostructures and growth of functional materials used as the building blocks for devices. Demonstration of optical and photonic devices by LIL is reviewed such as directed nanophotonics and surface plasmon resonance (SPR) or large area membrane reflectors and anti-reflectors. Perspective on future directions for LIL and emerging applications in other fields are presented.